Tor-Morten Kvam

Author information from the last article

Tor-Morten Kvam er ph.d.-kandidat, spesialist i psykiatri og overlege på Ketaminenheten ved DPS nordre Østfold i Moss og nestleder av forskningsteamet PsykForsk (gjennomfører kliniske studier med psykoterapeutisk intervensjon i kombinasjon med nye medisinske produkter).

Articles by Tor-Morten Kvam

Ketamine in treatment-resistant depression

Mark Berthold-Losleben,
Ingrid Autran,
Rikke Lise Steen Folstad,
Benedikt Römer,
Tor-Morten Kvam,
Inger-Tove van de Vooren,
Lowan H. Stewart,
Ingmar Claussen,
Ole A. Andreassen

24.04.2025: Ketamine has a rapid antidepressant effect and appears to be a safe and effective treatment option for treatment-resistant depression. Depression is a common, serious illness that has a major negative impact on individuals, their families and society. Cardinal symptoms include low mood, loss of...

Ketamine for depression – evidence and proposals for practice

Tor-Morten Kvam,
Lowan H. Stewart,
Andreas Wahl Blomkvist,
Ole A. Andreassen

25.10.2021: Current treatment for serious depression is unsatisfactory, and many patients fail to achieve the desired effect. Ketamine represents a new treatment option, and randomised trials show a rapid effect of intravenous ketamine. Although knowledge about adverse effects and the duration of the effect is...

Psychedelic drugs in the treatment of anxiety, depression and addiction

Tor-Morten Kvam,
Lowan H. Stewart,
Ole A. Andreassen

12.11.2018: In the 1950s and 60s, the classic psychedelic drugs lysergic acid diethylamide (LSD) and psilocybin were tested in numerous clinical trials. The results suggested efficacy against anxiety and depression in cases of life-threatening illness, unipolar depression and addiction (1–3). An open study of...